<SEC-DOCUMENT>0000950170-25-080021.txt : 20250602
<SEC-HEADER>0000950170-25-080021.hdr.sgml : 20250602
<ACCEPTANCE-DATETIME>20250602075929
ACCESSION NUMBER:		0000950170-25-080021
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250529
FILED AS OF DATE:		20250602
DATE AS OF CHANGE:		20250602

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			McCracken Joseph S
		CENTRAL INDEX KEY:			0001632454
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32157
		FILM NUMBER:		251013161

	MAIL ADDRESS:	
		STREET 1:		C/O NEXVET BIOPHARMA PLC
		STREET 2:		NATL INST, FOSTERS AVENUE, MOUNT MERRION
		CITY:			BLACKROCK
		STATE:			L2
		ZIP:			00000

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Savara Inc
		CENTRAL INDEX KEY:			0001160308
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				841318182
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		6836 BEE CAVE ROAD
		STREET 2:		BUILDING 3, SUITE 201
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746
		BUSINESS PHONE:		51285113796

	MAIL ADDRESS:	
		STREET 1:		6836 BEE CAVE ROAD
		STREET 2:		BUILDING 3, SUITE 201
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78746

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Mast Therapeutics, Inc.
		DATE OF NAME CHANGE:	20130312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVENTRX PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20030613

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOKEYS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20010928
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2025-05-29</periodOfReport>

    <issuer>
        <issuerCik>0001160308</issuerCik>
        <issuerName>Savara Inc</issuerName>
        <issuerTradingSymbol>SVRA</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001632454</rptOwnerCik>
            <rptOwnerName>McCracken Joseph S</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>ONE SUMMIT SQUARE,</rptOwnerStreet1>
            <rptOwnerStreet2>1717 LANGHORNE NEWTOWN ROAD, SUITE 300</rptOwnerStreet2>
            <rptOwnerCity>LANGHORNE</rptOwnerCity>
            <rptOwnerState>PA</rptOwnerState>
            <rptOwnerZipCode>19047</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
            <isOfficer>false</isOfficer>
            <isTenPercentOwner>false</isTenPercentOwner>
            <isOther>false</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>false</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2025-05-29</value>
            </transactionDate>
            <deemedExecutionDate>
                <value>2025-05-29</value>
            </deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>P</transactionCode>
                <equitySwapInvolved>false</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>10000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>2.0825</value>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>260837</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The price is a weighted average purchase price. The purchase prices ranged from $2.08 to $2.085. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ David Lowrance as attorney-in-fact for Joseph S. McCracken</signatureName>
        <signatureDate>2025-06-02</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
